Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 4479 (117th)

Facilitating Innovative Nuclear Diagnostics Act of 2021

referredUnited States· United States Congress· EN

Introduced

16 July 2021

Last action

19 July 2021 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Peters, Scott H. [D-CA-50], Rep. Rush, Bobby L. [D-IL-1], Rep. Dunn, Neal P. [R-FL-2], Rep. Murphy, Gregory F. [R-NC-3], Rep. Payne, Donald M., Jr. [D-NJ-10], Rep. Reschenthaler, Guy [R-PA-14], Rep. Burchett, Tim [R-TN-2], Rep. Krishnamoorthi, Raja [D-IL-8], Sen. Mullin, Markwayne [R-OK], Rep. McKinley, David B. [R-WV-1], Rep. McGovern, James P. [D-MA-2], Rep. Moulton, Seth [D-MA-6], Rep. Smith, Christopher H. [R-NJ-4], Rep. Cárdenas, Tony [D-CA-29], Rep. Tonko, Paul [D-NY-20], Rep. Kuster, Ann M. [D-NH-2], Rep. Sewell, Terri A. [D-AL-7], Sen. Blunt Rochester, Lisa [D-DE], Rep. Smith, Adrian [R-NE-3], Rep. Soto, Darren [D-FL-9], Rep. Lieu, Ted [D-CA-36], Rep. Watson Coleman, Bonnie [D-NJ-12], Rep. Trahan, Lori [D-MA-3], Rep. Rutherford, John H. [R-FL-5], Rep. Walorski, Jackie [R-IN-2], Rep. Van Drew, Jefferson [R-NJ-2], Rep. Auchincloss, Jake [D-MA-4], Rep. Posey, Bill [R-FL-8], Rep. Johnson, Bill [R-OH-6], Rep. Lowenthal, Alan S. [D-CA-47], Rep. Carbajal, Salud O. [D-CA-24], Rep. Craig, Angie [D-MN-2], Rep. Bucshon, Larry [R-IN-8], Rep. Ferguson, A. Drew, IV [R-GA-3], Rep. Malinowski, Tom [D-NJ-7], Rep. Carter, Earl L. "Buddy" [R-GA-1], Rep. Phillips, Dean [D-MN-3], Rep. Armstrong, Kelly [R-ND-At Large], Rep. Joyce, John [R-PA-13], Rep. Carson, André [D-IN-7], Rep. Pappas, Chris [D-NH-1], Rep. Miller-Meeks, Mariannette [R-IA-1]

Subjects

Healthcare

Source updated

5 December 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Facilitating Innovative Nuclear Diagnostics Act of 2021 This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2022 and as adjusted based on a specified fee schedule factor in each year thereafter.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 16 July 2021

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  2. 16 July 2021

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  3. 16 July 2021

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 16 July 2021

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 19 July 2021

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 16 July 2021

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 16 July 2021

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 16 July 2021

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.